PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a ...
Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...
ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert. These include electrode placement, shock polarity, ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
I recently diagnosed atrial fibrillation in a 24-year-old man with new-onset chest pain, irregular palpitations, and heart rate >170 beats per minute. The patient has no history of drug or tobacco ...
The Vanta device by Medtronic plc, provides relief from pain for thousands of patients, but the Vanta might also feel the pain when the patient is undergoing cardioversion. According to a field safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results